Sign in

CIK 0001770121

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sana Biotechnology, Inc.

Sign in to watch
Ticker
SANA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831381173
Phone
+1 206-701-7914
Business address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
  1. 4 Open-market sale EVP, Head of Development & CMO sold 60,000 shares at an average $26.07 ($1,564,057)
  2. 4 Open-market sale EVP, Chief Business Officer sold 1,477 shares at $25.00 ($36,925)
  3. 4 Open-market sale EVP, Chief Business Officer sold 64,671 shares at an average $25.01 ($1,617,491)
  4. 4 Open-market sale EVP, Chief Business Officer sold 8,658 shares at an average $25.00 ($216,468)
  5. 4 Open-market sale EVP, Chief Business Officer sold 4,136 shares at an average $25.01 ($103,421)
  6. 4 Open-market sale EVP, Chief Business Officer sold 2,300 shares at an average $25.01 ($57,533)
  7. 4 Other acquisition Director acquired 12,500 shares (other)
  8. 4/A Derivatives Options or other derivatives
  9. 4/A Derivatives Options or other derivatives
  10. 4/A Derivatives Options or other derivatives
  11. 4/A Derivatives Options or other derivatives
  12. 4/A Derivatives Options or other derivatives
  13. 4/A Derivatives Options or other derivatives
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. 4/A Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 4 Conversion 10% owner acquired 43,750,000 shares (conversion)
  19. 4 Conversion 10% owner acquired 43,750,000 shares (conversion)
  20. 4 Conversion Director acquired 2,031,250 shares (conversion)

Page 8 of 10 · 193 filings